EDBI logo

EDBI

Asia, Central Region, Singapore, Singapore

Description

EDBI, or EDB Investments, stands as the dedicated corporate investment arm of the Singapore Economic Development Board (EDB), a statutory board under Singapore's Ministry of Trade and Industry. Operating as a global fund, EDBI plays a pivotal role in shaping Singapore's economic landscape by investing in knowledge and innovation-intensive sectors worldwide. Its strategic mandate extends beyond mere financial returns, aiming to attract and grow companies that contribute significantly to Singapore's economic development, foster high-value job creation, and enhance the nation's technological capabilities.

The firm focuses its investments across four key pillars: Healthcare, encompassing biotechnology, medical technology, and digital health; New Technologies, which includes areas like artificial intelligence, robotics, cybersecurity, and advanced manufacturing; Smart & Sustainable Cities, focusing on urban solutions and clean energy; and Emerging Growth, targeting high-potential companies aligned with Singapore's future economic strategies. EDBI typically targets growth-stage companies, often participating in Series B rounds and beyond, though it also considers strategic Series A investments for companies demonstrating strong potential for establishing a significant presence or R&D footprint in Singapore. They seek companies with validated technologies, clear market traction, and a scalable business model.

EDBI's investment cheques typically range from US$3.7 million to US$37 million per company, with the flexibility for larger strategic commitments. This reflects their capacity to support substantial growth and development initiatives. Beyond capital, EDBI actively leverages its extensive network and deep understanding of the Asian market to help portfolio companies expand into Southeast Asia and establish strategic partnerships. Their unique position as a government-backed investor allows them to offer not just funding, but also invaluable support in navigating regulatory landscapes, accessing talent, and fostering an environment conducive to innovation and long-term growth within Singapore.

Investor Profile

EDBI has backed more than 171 startups, with 14 new investments in the last 12 months alone. The firm has led 32 rounds, about 19% of its total and boasts 49 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Singapore, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Software.
  • Led 4 rounds in the past year.
  • Typical check size: $3.7M – $37M.

Stage Focus

  • Series C (24%)
  • Series B (18%)
  • Series D (16%)
  • Series A (13%)
  • Series Unknown (13%)
  • Series E (5%)
  • Seed (3%)
  • Series F (2%)
  • Private Equity (2%)
  • Series G (1%)

Country Focus

  • United States (60%)
  • Singapore (30%)
  • United Kingdom (2%)
  • Germany (2%)
  • India (2%)
  • Switzerland (1%)
  • Vietnam (1%)
  • Malaysia (1%)
  • China (1%)
  • Philippines (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Medical
  • Artificial Intelligence (Ai)
  • Information Technology
  • Pharmaceutical
  • Therapeutics
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EDBI frequently co-invest with?

Seeds Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 8
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 7
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 10
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 7
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 9
Openspace
Asia, Central Region, Singapore, Singapore
Co-Investments: 8
Peak XV Partners
Asia, Karnataka, India, Bengaluru
Co-Investments: 9
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 9
Invus
North America, New York, United States, New York
Co-Investments: 7

Which angels does EDBI often collaborate with?

AS
Asia, Singapore
Shared Deals: 1
PS
North America, California, United States
Shared Deals: 1
AT
North America, California, United States, Atherton
Shared Deals: 1
SD
North America, California, United States, Los Angeles
Shared Deals: 1
RC
North America, California, United States, San Francisco
Shared Deals: 2
BG
North America, Washington, United States, Seattle
Shared Deals: 1
RK
North America, California, United States, San Francisco
Shared Deals: 1
KV
Europe, England, United Kingdom, London
Shared Deals: 1
NC
North America, California, United States, Menlo Park
Shared Deals: 1
CS
North America, Washington, United States, Kirkland
Shared Deals: 1

What are some of recent deals done by EDBI?

HydroLeap

Singapore, Central Region, Singapore

Hydropleap provides advanced environmental-friendly technological water treatment solutions.

ManufacturingWaterWater Purification
Series AJul 30, 2025
Amount Raised: $4,750,000
Augmentus

Singapore, Central Region, Singapore

Leader in Robot Vision and Motion

Artificial Intelligence (AI)Industrial AutomationMachine LearningRoboticsSoftware
Series AJul 9, 2025
Amount Raised: $11,000,000
Tacta Systems

Palo Alto, California, United States

Tacta Systems develops robotics with human-like tactile abilities with Dextrous Intelligence, the nervous system for robots.

Artificial Intelligence (AI)Machine LearningRobotics
Series AJun 26, 2025
Amount Raised: $64,000,000
Multiplier

Singapore, Central Region, Singapore

Multiplier is a technology corporation that buys and transforms high-profile service businesses.

Information Technology
Series AJun 18, 2025
Amount Raised: $27,500,000
Allay Therapeutics

San Jose, California, United States

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

BiotechnologyHealth CareMedicalTherapeutics
Series DJun 5, 2025
Amount Raised: $57,500,000
Antheia

Menlo Park, California, United States

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

BiotechnologyHealth CareManufacturingPharmaceutical
Series CJun 3, 2025
Amount Raised: $56,000,000
VFlow Tech

Singapore, Central Region, Singapore

VFlow uses its unique IP to build safe, long-lasting, high performing low-cost flow batteries for large scale energy storage application.

BatteryElectronicsEnergyEnergy StorageRenewable EnergySoftware
Series BMay 14, 2025
Amount Raised: $20,500,000
Addepar

Mountain View, California, United States

Addepar is a software and data platform for even the most complex investment portfolios.

Financial ServicesFinTechSaaSSoftware
Series GMay 13, 2025
Amount Raised: $230,000,000
Nuevocor

Singapore, Central Region, Singapore

Nuevocor operates as a preclinical-stage biotech company.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BMay 6, 2025
Amount Raised: $45,000,000
Callio Therapeutics

Seattle, Washington, United States

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

BiotechnologyHealth CareMedical
Series AMar 3, 2025
Amount Raised: $187,000,000